NCT06559267 School-based Paraeducator Education for Engagement at Recess
| NCT ID | NCT06559267 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Washington |
| Condition | Autism Spectrum Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 350 participants |
| Start Date | 2024-07-01 |
| Primary Completion | 2029-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 350 participants in total. It began in 2024-07-01 with a primary completion date of 2029-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the proposed three-site study is to test whether an educator-level implementation strategy, coaching, with or without a school-level implementation strategy, school-based teams, will maximize paraeducators' use (fidelity and sustainment) of an evidence-based social engagement intervention, Remaking Recess (RR). RR aims to improve peer related social skills for autistic students and their non-autistic peers who are socially isolated or peripheral and need support during recess.
Eligibility Criteria
Inclusion Criteria: * Students: Elementary aged students in K-5th grade who are autistic or have a neurodevelopmental disorder (Age 5-12) * Educators: Paraeducators, teachers, or other school personnel that work with K-5th grade students in a public school in the United States (Age 18+) Exclusion Criteria: * Students or educators that have previously participated in Remaking Recess studies will not be eligible to enroll in this study.
Contact & Investigator
Freda Liu, PhD
PRINCIPAL INVESTIGATOR
University of Washington
Frequently Asked Questions
Who can join the NCT06559267 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06559267 currently recruiting?
Yes, NCT06559267 is actively recruiting participants. Contact the research team at chipokem@uw.edu for enrollment information.
Where is the NCT06559267 trial being conducted?
This trial is being conducted at Los Angeles, United States, Eugene, United States, Seattle, United States.
Who is sponsoring the NCT06559267 clinical trial?
NCT06559267 is sponsored by University of Washington. The principal investigator is Freda Liu, PhD at University of Washington. The trial plans to enroll 350 participants.